AU6167296A - Monoclonal antibody fragment to human ovarian cancers - Google Patents

Monoclonal antibody fragment to human ovarian cancers

Info

Publication number
AU6167296A
AU6167296A AU61672/96A AU6167296A AU6167296A AU 6167296 A AU6167296 A AU 6167296A AU 61672/96 A AU61672/96 A AU 61672/96A AU 6167296 A AU6167296 A AU 6167296A AU 6167296 A AU6167296 A AU 6167296A
Authority
AU
Australia
Prior art keywords
monoclonal antibody
antibody fragment
human ovarian
ovarian cancers
cancers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61672/96A
Inventor
Chaitanya R. Divgi
Mark G. Federici
Lale Kostakoglu
Kenneth O. Lloyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU6167296A publication Critical patent/AU6167296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU61672/96A 1995-06-07 1996-06-07 Monoclonal antibody fragment to human ovarian cancers Abandoned AU6167296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47819095A 1995-06-07 1995-06-07
US478190 1995-06-07
PCT/US1996/009819 WO1996040295A1 (en) 1995-06-07 1996-06-07 Monoclonal antibody fragment to human ovarian cancers

Publications (1)

Publication Number Publication Date
AU6167296A true AU6167296A (en) 1996-12-30

Family

ID=23898888

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61672/96A Abandoned AU6167296A (en) 1995-06-07 1996-06-07 Monoclonal antibody fragment to human ovarian cancers

Country Status (2)

Country Link
AU (1) AU6167296A (en)
WO (1) WO1996040295A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376654B1 (en) 1999-08-13 2002-04-23 Molecular Discoveries, Llc Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
US7226750B1 (en) 2000-08-08 2007-06-05 Molecular Discoveries, Inc. Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
EP1992643A3 (en) * 2001-06-20 2008-12-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6987270B2 (en) 2003-05-07 2006-01-17 General Electric Company Method to account for event losses due to positron range in positron emission tomography and assay of positron-emitting isotopes

Also Published As

Publication number Publication date
WO1996040295A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
GB9504344D0 (en) Antibody fragment production
AU5365296A (en) Human monoclonal antibody against lung carcinoma
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU1704099A (en) Monoclonal human natural antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
PL349266A1 (en) Human monoclonal antibodies to ctla-4
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU6172096A (en) High affinity human monoclonal antibodies specific for RSV F-protein
IL130864A0 (en) Monoclonal antibodies to human cd6
AU1289795A (en) Monoclonal antibodies specific for human interleukin-5
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU6155896A (en) Humanized antibodies to e-selectin
EP0977590A4 (en) Human monoclonal antibodies
AU4256096A (en) Monoclonal antibody fragments having immunosuppressant activity
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
AU6167296A (en) Monoclonal antibody fragment to human ovarian cancers
AU3552689A (en) Monoclonal antibody for colorectal carcinoma
AU1809695A (en) Tumor associated monoclonal antibody 123av16
AU2170692A (en) Me20: monoclonal antibodies and antigen for human melanoma
AU6777594A (en) Human monoclonal antibodies to human cytomegalovirus, and methods therefor
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes
GB9718911D0 (en) Monoclonal antibodies